Trial Profile
Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Safinamide (Primary) ; Diclofenac
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Zambon SpA
- 15 Jul 2015 New trial record